2019
18 December, 2019
Takeda and Cerevance Team Up to Take on GI Diseases
17 December, 2019
Nimbus Therapeutics Appoints Chief Medical Officer Annie C. Chen, M.D., MPH, to President of the Company’s Tyk2 Subsidiary
16 December, 2019
Catabasis Pharmaceuticals Announces Phase 3 PolarisDMD Trial Enrolled Expected Patient Population
10 December, 2019
Locana Expands Leadership Team with Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer
18 November, 2019
MedTech Strategist Innovation Summit San Francisco 2019
8 October, 2019
12 VCs who matter in biotech, but you hardly ever read about
30 September, 2019
Catabasis Pharmaceuticals Announces The Phase 3 PolarisDMD Trial Of Edasalonexent In Duchenne Muscular Dystrophy Has Exceeded Target Enrollment
13 September, 2019
Gemini Therapeutics Announces Leadership Appointment
4 September, 2019
Cala Health Names Veteran Leader Renee Ryan as Chief Executive Officer
31 July, 2019
Professor Dario Campana wins prestigious Gabbay Award
28 June, 2019
Carrick Therapeutics Announces Plan to Establish US Operations and Appointment of Tim Pearson as CEO
12 June, 2019
MDA Awards Venture Philanthropy Grant to Locana to Develop Novel Treatment for Muscular Dystrophy
21 May, 2019
Cala Health raises $50M ahead of commercial launch of its bioelectric stimulation device
30 April, 2019
Cerevance Achieves Key Endpoints in Phase 1 Clinical Trial of Novel Parkinson’s Disease Drug CVN424
9 April, 2019
MedTech Strategist Innovation Summit Dublin 2019
8 April, 2019
Tackling the Burden and Shame of Hearing Loss
18 March, 2019
Alcon Announces Acquisition of PowerVision, Inc.
18 March, 2019
Alcon Acquires PowerVision for $285 Million
5 March, 2019
Industry Central Nervous System Specialist Lee Dawson, Ph.D. Joins Cerevance as VP of Neuroscience
28 February, 2019
Ra Pharmaceuticals Supports 12th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases
21 February, 2019
Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis
11 February, 2019
Nuvaira Announces a $79 Million Financing Round to Pursue Groundbreaking Treatment of COPD
6 January, 2019
Willow unveils a new version of its smart breast pump
3 January, 2019
AbbVie and Tizona Therapeutics Announce Strategic Collaboration to Develop First-in-Class Immunotherapy for Cancer Targeting CD39
2018
27 November, 2018
Catabasis Pharmaceuticals Announces Publication Of Phase 1 Clinical Results Of Edasalonexent (CAT-1004) In Duchenne Muscular Dystrophy
7 November, 2018
ALX Oncology Presents Updated Data from ALX148 Clinical Trial Combination Cohorts for the Treatment of Patients with Advanced Solid Tumors
3 November, 2018
Disarm Therapeutics Presents New Data Validating Role of SARM1 in Axonal Degeneration
11 October, 2018
Carrick Therapeutics In-Licenses Targeted Ovarian Cancer Treatment From BTG and Appoints George Golumbeski as Chairman
25 September, 2018
Cerevance Announces First-in-Human Dosing of CVN424 for the Treatment of Parkinson’s Disease
25 September, 2018
Catabasis Pharmaceuticals Initiates Phase 3 PolarisDMD Clinical Trial For Edasalonexent In Duchenne Muscular Dystrophy
14 March, 2018
Stanford/NVCA Venture Capital Symposium
30 January, 2018
FIRE1 raises $50M to develop remote heart monitoring device
2017
16 November, 2017
Willow Named TIME Magazine 2017 Best Inventions
15 November, 2017
12 VCs who matter in biotech, but you never read about
14 November, 2017
EndoGastric® Solutions Announces Further Expansion of Medicare Reimbursement for Transoral Incisionless Fundoplication (TIF®) 2.0 Procedure
10 November, 2017
Alexo Therapeutics Presents Preliminary Results from ALX148 Phase 1 Clinical Trial in Patients with Advanced Solid Tumors and Lymphoma
17 October, 2017
Armed with $42.5M, Gemini embraces the Goldilocks strategy in bringing precision med to AMD
5 October, 2017
Arming Bodies with CRISPR to Fight Huntington’s Disease and ALS
3 October, 2017
Celgene pens pact to join Bristol-Myers, Pfizer in R&D race
27 September, 2017
One Tech Company’s Revolutionary Idea: Design For Mothers First
20 September, 2017
Lightstone Ventures Closes New Life Sciences Fund at $250 Million
11 September, 2017
MediSix Therapeutics Signs Exclusive Licensing Agreement with the National University of Singapore
29 July, 2017
Biotech sector poised to deliver more health and wealth
5 June, 2017
Claret Medical Receives FDA Clearance to Market Sentinel Cerebral Protection System in the U.S.
21 April, 2017
Gilead says first data on Nimbus NASH candidate are positive
10 April, 2017
Alexo Therapeutics Announces Initiation of Phase 1 Clinical Trial of ALX148 for the Treatment of Advanced Solid Tumors and Lymphoma
16 March, 2017
Moximed closes $50m Series C
16 March, 2017
Moximed Closes Oversubscribed $50MM Financing Round
14 March, 2017
Comparison of Real-world Bandwidth in Hearing Aids vs Earlens Light-driven Hearing Aid System
27 February, 2017
FDA Advisory Committee Strongly Supports Granting De Novo Application For The First Cerebral Protection System For Transcatheter Aortic Valve Replacement (TAVR)
23 January, 2017
PowerVision – FierceMedicalDevices’ 2016 Fierce 15
9 January, 2017
Foundry SING1 Launches, Targets Asian Clinical Needs
5 January, 2017
The Willow could be the iPhone of breast pumps
5 January, 2017
Willow’s smart breast pumps slide into moms’ bras
2016
22 December, 2016
Is Med Tech Venture Investment Waning?
20 December, 2016
Finishing Strong in 2016: NVCA Policy Victories in the Last Few Weeks
17 November, 2016
Ra Pharmaceuticals Receives Orphan Drug Designation in the European Union for RA101495 for Treatment of Paroxysmal Nocturnal Hemoglobinuria
1 November, 2016
Fast biotech: Gilead hands $200M to computational wiz Nimbus as it speeds into PhII NASH trial
1 November, 2016
Results from U.S. Pivotal IDE Trial Show That Sentinel Cerebral Protection System Protects Patients During Transcatheter Aortic Valve Replacement
26 October, 2016
Ra Pharmaceuticals Announces Pricing of Initial Public Offering
18 October, 2016
Durable Treatment Of GERD With TIF 2.0: A Surgical Products Q&A
11 October, 2016
Relievant Medsystems raises $36m
11 October, 2016
Second Genome Partners with King’s College London to Evaluate the Influence of the Microbiome in Landmark EAT Study
4 October, 2016
New Startup Carrick Therapeutics Launches With $95 Million and Taps Former AstraZeneca PLC-Eli Lilly Exec as CEO
3 October, 2016
Taking Aim at Alexion, Ra Pharma Heads to IPO Queue
26 September, 2016
EndoGastric Solutions Announces Publication of Long-Term Data Demonstrating TIF® 2.0 Procedure Offers Durable Treatment of Chronic GERD
20 September, 2016
CLARET MEDICAL SUBMITS MARKETING APPLICATION TO FDA FOR US CLEARANCE OF FIRST CEREBRAL PROTECTION SYSTEM FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)
14 September, 2016
CLARET MEDICAL ANNOUNCES SENTINEL PIVOTAL IDE TRIAL TO BE FEATURED IN LATE-BREAKING TRIAL SESSION AT TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT) CONFERENCE
7 September, 2016
Lightstone Ventures Adds Susan Molineaux as Scientific Advisor
6 September, 2016
Monsanto Collaborates with Second Genome to use Microbiome Technology Platform to Accelerate Protein Discovery
5 September, 2016
Holaira Hosts Educational Symposium on Targeted Lung Denervation (TLD) in Obstructive Lung Disease at ERS
29 August, 2016
Endovascular Filter Device Helps Prevent Periprocedural Stroke
24 August, 2016
Device treats severe heartburn at the source
24 August, 2016
Second Genome’s new CEO looks to neighboring Genentech as a model for pioneering a new field
3 August, 2016
First COPD Patient Treated in Holaira’s Sham Controlled Trial of Targeted Lung Denervation
21 July, 2016
Relievant Medsystems wins FDA clearance for Intracept ablation device for low back pain
8 July, 2016
Acceleron Announces ACE-083 Phase 1 Results at the 14th International Congress on Neuromuscular Diseases
5 July, 2016
EndoGastric Solutions touts U.S. reimbursement win
21 April, 2016
Novartis’ Alcon Partners With Eye Device Startup PowerVision
12 April, 2016
Medtronic backs stealthy Foundry startup as it nabs $7.5M for novel remote patient monitoring
12 April, 2016
FIRE1 Closes Series B Financing, Announces New CEO
23 March, 2016
GI Dynamics Announces the Appointment of Medical Device Industry Veteran Scott Schorer as President & Chief Executive Officer
18 February, 2016
Crossing paths LINKING INFLAMMATION AND OXIDATION IN ALS
18 February, 2016
New life sciences fund gets $71m boost
16 February, 2016
Stealth Stanford spinout Cala Health raises $18M for wearable device that treats hand and wrist tremors
9 February, 2016
Unraveling the Mysterious Function of the Microbiome
19 January, 2016
EarLens hearing aid uses laser light to transmit sound
2015
15 December, 2015
Panelists Select 19 Companies for the 2016 Small-Cap Biotech Watchlist
14 December, 2015
CE Mark in hand, Moximed hatches U.S. approval strategy for knee stabilization implant
10 December, 2015
ACCOMMODATIVE IOL PROVIDES GOOD VISUAL ACUITY
10 December, 2015
Promedior Presents Positive Phase 2 Data for PRM-151 in Myelofibrosis at ASH Annual Meeting
26 October, 2015
Promise of new non-addictive painkillers to address opiate crisis highlighted in panel
15 October, 2015
Five Prime, Bristol Shake Hands Again in New $350M Cancer Pact
14 October, 2015
FierceMedicalDevices’ 2015 Fierce 15
29 September, 2015
FDA Permits Marketing Of New Laser-Based Hearing Aid With Potential For Broad Sound Amplification
9 September, 2015
EndoGastric Solutions Announces AMA Assignment of CPT Code and Short Form Descriptor
25 August, 2015
Medtronic to buy Twelve for $408M+, joining Abbott and Edwards on the transcatheter mitral valve bandwagon
6 August, 2015
Lightstone’s Lettmann Finding Opportunities in Ireland
23 July, 2015
Ra Pharmaceuticals Announces $58.5M Series B Financing
7 May, 2015
Moximed Closes $33MM Financing Round
18 March, 2015
Evotec pairs up with Second Genome to gut out some R&D
12 March, 2015
GERD Device Maker Uses Clinical Data to Prove Its Point
1 March, 2015
A Fluid-Based Accommodating IOL
28 January, 2015
Flex Pharma Announces Pricing Of Initial Public Offering
22 January, 2015
GERD transoral surgical startup releases sham-controlled data as it awaits reimbursement code
12 January, 2015
Second Genome Advances Lead Microbiome Drug Development Program in Phase I Clinical Trial as a Treatment for Inflammatory Bowel Disease
7 January, 2015
What’s Lurking In Your Microbiome? Possibly, A Cure For Disease
2014
7 October, 2014
Holaira Announces First Patient Treatment in Randomized Study of Targeted Lung Denervation for COPD
4 August, 2014
Addressing the challenges in medical innovation: VCJ
24 June, 2014
Human microbiome: Boon or boondoggle for drugmakers?
11 June, 2014
LSV Appoints Two New Venture Partners
11 June, 2014
NVCA Members Testify at Congressional Hearing on Incentives to Advance Medical Research and Development
21 May, 2014
New €125m fund to boost innovative firms
3 April, 2014
Plymouth-based Holaira raises $42 million
27 March, 2014
The Top Life Sciences Investors Of 2014
25 March, 2014